Serge Saxonov 10x Genomics, Inc. (TXG) insider trading activity

Serge Saxonov is Chief Executive Officer of 10x Genomics, Inc.. Currently has a direct ownership of 1.09 Million shares of TXG, which is worth approximately $9.54 Million. The most recent transaction as insider was on Mar 17, 2025, when has been sold 171,428 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.09M

23.56% 3M change

22.19% 12M change

Total Value Held $9.54 Million

Serge Saxonov Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 17 2025	BUY Grant, award, or other acquisition	-	171,428 Added 13.56%	1,092,968 Class A Common Stock
Mar 04 2025	BUY Exercise of conversion of derivative security	$60,000 $1.2 p/Share	50,000 Added 5.15%	921,540 Class A Common Stock
Feb 28 2025	SELL Open market or private sale	$84,423 $10.63 p/Share	7,942 Reduced 0.9%	871,540 Class A Common Stock
Feb 24 2025	SELL Open market or private sale	$56,368 $11.07 p/Share	5,092 Reduced 0.58%	879,482 Class A Common Stock
Dec 23 2024	BUY Exercise of conversion of derivative security	$14,400 $1.2 p/Share	12,000 Added 1.34%	884,574 Class A Common Stock
Nov 22 2024	SELL Open market or private sale	$91,627 $13.69 p/Share	6,693 Reduced 0.76%	872,574 Class A Common Stock
Nov 21 2024	SELL Bona fide gift	-	1,850 Reduced 0.21%	879,267 Class A Common Stock
Nov 14 2024	SELL Bona fide gift	-	1,350 Reduced 0.15%	881,117 Class A Common Stock
Aug 22 2024	SELL Open market or private sale	$152,054 $22.53 p/Share	6,749 Reduced 0.76%	882,467 Class A Common Stock
May 29 2024	SELL Bona fide gift	-	425 Reduced 0.05%	889,216 Class A Common Stock
May 22 2024	SELL Open market or private sale	$118,511 $24.3 p/Share	4,877 Reduced 0.55%	889,641 Class A Common Stock
Mar 21 2024	BUY Grant, award, or other acquisition	-	88,854 Added 9.04%	894,518 Class A Common Stock
Mar 14 2024	SELL Bona fide gift	-	1,086 Reduced 0.13%	805,664 Class A Common Stock
Mar 04 2024	SELL Open market or private sale	$205,040 $44.0 p/Share	4,660 Reduced 0.55%	842,900 Class A Common Stock
Feb 22 2024	SELL Open market or private sale	$130,725 $46.34 p/Share	2,821 Reduced 0.33%	847,560 Class A Common Stock
Feb 15 2024	SELL Open market or private sale	$245,050 $49.01 p/Share	5,000 Reduced 0.58%	850,381 Class A Common Stock
Feb 09 2024	SELL Open market or private sale	$49,530 $49.53 p/Share	1,000 Reduced 0.12%	855,381 Class A Common Stock
Jan 16 2024	SELL Open market or private sale	$181,520 $45.38 p/Share	4,000 Reduced 0.46%	856,381 Class A Common Stock
Dec 27 2023	BUY Exercise of conversion of derivative security	$17,922 $1.2 p/Share	14,935 Added 1.71%	860,381 Class A Common Stock
Dec 14 2023	SELL Open market or private sale	$109,540 $54.77 p/Share	2,000 Reduced 0.24%	845,446 Class A Common Stock
Nov 24 2023	SELL Open market or private sale	$162,769 $43.72 p/Share	3,723 Reduced 0.44%	847,446 Class A Common Stock
Nov 22 2023	SELL Open market or private sale	$162,828 $43.34 p/Share	3,757 Reduced 0.44%	851,169 Class A Common Stock
Nov 14 2023	SELL Open market or private sale	$79,040 $39.52 p/Share	2,000 Reduced 0.23%	854,926 Class A Common Stock
Oct 17 2023	SELL Open market or private sale	$78,190 $39.51 p/Share	1,979 Reduced 0.23%	856,926 Class A Common Stock
Oct 16 2023	SELL Open market or private sale	$829 $39.5 p/Share	21 Reduced 0.0%	858,905 Class A Common Stock

Serge Saxonov

Chief Executive Officer

Pleasanton, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXG shares.

Notify only if

Value

Insider Trading

Get notified when an 10x Genomics, Inc. insider buys or sells TXG shares.

Notify only if

Operation

Value

Type

News

Receive news related to 10x Genomics, Inc.

Track Activities on TXG

Account